Clinical Trial Update: TAVR for Aortic Valve Disease

View source ↗

Summary

A clinical trial sponsored by Nanjing First Hospital and Nanjing Medical University is recruiting to evaluate transcatheter aortic valve replacement (TAVR) for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• Transcatheter aortic valve replacement device (transcatheter aortic valve prosthesis)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Aortic Valve Disease | Status: RECRUITING